Epidermal and dermal integration into sphere-templated porous poly(2-hydroxyethyl methacrylate) implants in mice

Journal of Biomedical Materials Research - Part A

Volumn 94, Issue 4, 2010, Pages 1172-1186

  Fukano, Y ^a   Usui, M L ^a   Underwood, R A ^a   Isenhath, S ^a   Marshall, A J ^b,c   Hauch, K D ^b,c   Ratner, B D ^b,c   Olerud, J E ^a   Fleckman, P ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b University of Washington   (United States)

^c University of Washington   (United States)

Author keywords

Biointegration; Biomaterial; Percutaneous; Skin; Wound healing

Indexed keywords

BACTERIAL ATTACHMENT; BACTERIAL CHALLENGE; BASEMENT MEMBRANE; BIOFILM FORMATION; BIOINTEGRATION; C57BL/6 MICE; CARBONYLDIIMIDAZOLE; CLINICAL SIGNS; DERMAL COLLAGEN; DEVICE FAILURES; EPIDERMAL LAYERS; FIBROUS CAPSULE FORMATION; INFLAMMATORY CELLS; INTEGRINS; KERATINOCYTES; KEY ELEMENTS; LAMININ; MEDICAL DEVICES; PERCUTANEOUS; PERCUTANEOUS DEVICES; POLY (2HYDROXYETHYL METHACRYLATE); TEMPLATED; TEMPLATED POLYMERS; WOUND HEALING;

BACTERIOLOGY; BIOLOGICAL MEMBRANES; BIOMATERIALS; BIOMEDICAL ENGINEERING; BLOOD VESSELS; CELL CULTURE; COLLAGEN; LIGHT TRANSMISSION; SPHERES; TISSUE; TRANSMISSION ELECTRON MICROSCOPY;

ENDOTHELIAL CELLS;

BETA4 INTEGRIN; COLLAGEN TYPE 7; KALININ; POLYMACON;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CELL ADHESION; DERMIS; DERMOEPIDERMAL JUNCTION; ENDOTHELIUM CELL; EPIDERMIS; FIBROBLAST; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; KERATINOCYTE; MALE; MOUSE; NONHUMAN; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; DERMIS; EPIDERMIS; IMMUNOHISTOCHEMISTRY; IMPLANTS, EXPERIMENTAL; MACROPHAGES; METHACRYLATES; MICE; MICE, INBRED C57BL; PHENOTYPE; POROSITY; TISSUE FIXATION;

EID: 77956456515     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32798     Document Type: Article

References (65)

1. von Recum AF. Applications and failure modes of percutaneous devices: A review. J Biomed Mater Res 1984;18:323-336. (Pubitemid 14101917)
2. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002;51(RR-10):1-29.
3. Crnich CJ, Maki DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. II. Long-term devices. Clin Infect Dis 2002;34:1362-1368.
4. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000;132:391-402.
5. Mermel LA. Correction: Prevention of intravascular catheter-related infections. Ann Intern Med 2000;133:395.
6. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994;271:1598-1601.
7. Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: A systematic review of 200 published prospective studies. Mayo Clin Proc 2006;81:1159-1171.
8. Pear R. Medicare says it won't cover hospital errors. New York Times, Aug 18, 2007. Available at: http//www.nytimes.com.
9. Heaney TG, Doherty PJ, Williams DF. Marsupialization of percutaneous implants in presence of deep connective tissue. J Biomed Mater Res 1996;32:593-601.
10. Winter GD. Transcutaneous implants: Reactions of the skinimplant interface. J Biomed Mater Res 1974;8:99-113.
11. Fleckman P, Olerud JE. Models for the histologic study of the skin interface with percutaneous biomaterials. Biomed Mater 2008;3:034006.
12. Susin C, Qahash M, Hall J, Sennerby L, Wikesjo UM. Histological and biomechanical evaluation of phosphorylcholine-coated titanium implants. J Clin Periodontol 2008;35:270-275.
13. Chin CD, Khanna K, Sia SK. A microfabricated porous collagen-based scaffold as prototype for skin substitutes. Biomed Microdev 2008;10:459-467.
14. Isenhath SN, Fukano Y, Usui ML, Underwood RA, Irvin CA, Marshall AJ, Hauch KD, Ratner BD, Fleckman P, Olerud JE. A mouse model to evaluate the interface between skin and a percutaneous device. J Biomed Mater Res A 2007;83:915-922.
15. Fukano Y, Knowles NG, Usui ML, Underwood RA, Hauch KD, Marshall AJ, Ratner BD, Giachelli C, Carter WG, Fleckman P, Olerud JE. Characterization of an in vitro model for evaluating the interface between skin and percutaneous biomaterials. Wound Repair Regen 2006;14:484-491.
16. Yannas IV. Synthesis of tissues and organs. Chembiochem 2004;5:26-39.
17. Gerritsen M, Lutterman JA, Jansen JA. The influence of impaired wound healing on the tissue reaction to percutaneous devices using titanium fiber mesh anchorage. J Biomed Mater Res A 2000;52:135-141.
18. Tagusari O, Yamazaki K, Litwak P, Kojima A, Klein EC, Antaki JF, Watach M, Gordon LM, Kono K, Mori T, Koyanagi H, Griffith BP, Kormos RL. Fine trabecularized carbon: ideal material and texture for percutaneous device system of permanent left ventricular assist device. Artif Organs 1998;22:481-487.
19. Sclafani AP, Romo T III, Silver L. Clinical and histologic behavior of exposed porous high-density polyethylene implants. Plast Reconstr Surg 1997;99:41-50. (Pubitemid 27020719)
20. Shin Y, Akao M. Tissue reactions to various percutaneous materials with different surface properties and structures. Artif Organs 1997;21:995-1001.
21. Tsuruga E, Takita H, Itoh H, Wakisaka Y, Kuboki Y. Pore size of porous hydroxyapatite as the cell-substratum controls BMP-induced osteogenesis. J Biochem 1997;121:317-324.
22. Berthod F, Saintigny G, Chretien F, Hayek D, Collombel C, Damour O. Optimization of thickness, pore size and mechanical properties of a biomaterial designed for deep burn coverage. Clin Mater 1994;15:259-265.
23. van Mullem PJ, Vaandrager JM, Nicolai JP, de Wijn JR. Implantation of porous acrylic cement in soft tissues: An animal and human biopsy histological study. Biomaterials 1990;11:299-304.
24. Squier CA, Collins P. The relationship between soft tissue attachment, epithelial downgrowth and surface porosity. J Periodont Res 1981;16:434-440. (Pubitemid 11008744)
25. Ashman A, Moss ML. Implantation of porous polymethylmethacrylate resin for tooth and bone replacement. J Prosthet Dent 1977;37:657-665.
26. Pilliar RM, Cameron HU, Macnab I. Porous surface layered prosthetic devices. Biomed Eng 1975;10:126-131.
27. Knowles NG, Miyashita Y, Usui ML, Marshall AJ, Pirrone A, Hauch KD, Ratner BD, Underwood RA, Fleckman P, Olerud JE. A model for studying epithelial attachment and morphology at the interface between skin and percutaneous devices. J Biomed Mater Res A 2005;74:482-488.
28. Kunzker JF, McGee JA. Contact lens materials. Chem Ind 1995;16:56-60.
29. Ratner BD, Marshall AJ. U.S. Pat. 20,080,075,752, 2008.
30. Marshall AJ, Ratner BD. Quantitative characterization of sphere-templated porous biomaterials. AIChE J 2005;51:1221-1232.
31. Marshall AJ, Irvin CA, Barker T, Sage EH, Hauch KD, Ratner BD. Biomaterials with tightly controlled pore size that promote vascular in-growth. Polym Prepr 2004;45:100-101.
32. Karnovsky MJ. A formaldehyde-glutaraldehyde fixative of high osmolarity for use in electron microscopy. J Cell Biol 1965;27:137(abstract).
33. Luft JH. Improvements in epoxy resin embedding methods. J Biophys Biochem Cytol 1961;9:409-414.
34. Richardson KC, Jarett L, Finke EH. Embedding in epoxy resins for ultrathin sectioning in electron microscopy. Stain Technol 1960;35:313-323.
35. Reynolds ES. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol 1963;17:208-212.
36. Sullivan SR, Underwood RA, Gibran NS, Sigle RO, Usui ML, Carter WG, Olerud JE. Validation of a model for the study of multiple wounds in the diabetic mouse (db/db). Plast Reconstr Surg 2004;113:953-960. (Pubitemid 39195758)
37. Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol 2008;20:86-100.
38. Ryan MC, Lee K, Miyashita Y, Carter WG. Targeted disruption of the LAMA3 gene in mice reveals abnormalities in survival and late stage differentiation of epithelial cells. J Cell Biol 1999;145:1309-1323.
39. Fitton JH, Dalton BA, Beumer G, Johnson G, Griesser HJ, Steele JG. Surface topography can interfere with epithelial tissue migration. J Biomed Mater Res 1998;42:245-257.
40. Burgeson RE. Type VII collagen, anchoring fibrils, and epidermolysis bullosa. J Invest Dermatol 1993;101:252-255.
41. Takeda H, Kon A, Ito N, Sawamura D, Takagaki K, Hashimoto I, Hanada K. Keratinocyte-specific modulation of type VII collagen gene expression by pro-inflammatory cytokines (tumor necrosis factor-alpha and interleukin-1beta). Exp Dermatol 2005;14:289-294. (Pubitemid 40485457)
42. Woodley DT, Krueger GG, Jorgensen CM, Fairley JA, Atha T, Huang Y, Chan L, Keene DR, Chen M. Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone. J Invest Dermatol 2003;121:1021-1028.
43. Ryynanen M, Ryynanen J, Sollberg S, Iozzo RV, Knowlton RG, Uitto J. Genetic linkage of type VII collagen (COL7A1) to dominant dystrophic epidermolysis bullosa in families with abnormal anchoring fibrils. J Clin Invest 1992;89:974-980.
44. Goto M, Sawamura D, Ito K, Abe M, Nishie W, Sakai K, Shibaki A, Akiyama M, Shimizu H. Fibroblasts show more potential as target cells than keratinocytes in COL7A1 gene therapy of dystrophic epidermolysis bullosa. J Invest Dermatol 2006;126:766-772.
45. Coutu DL, Yousefi AM, Galipeau J. Three-dimensional porous scaffolds at the crossroads of tissue engineering and cell-based gene therapy. J Cell Biochem 2009;108:537-546.
46. Kidd KR, Nagle RB, Williams SK. Angiogenesis and neovascularization associated with extracellular matrix-modified porous implants. J Biomed Mater Res A 2002;59:366-377.
47. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999;341:738-746.
48. Martin P. Wound healing - Aiming for perfect skin regeneration. Science 1997;276:75-81. (Pubitemid 27161246)
49. Bryant R. Wound repair: A review. J Enterostomal Ther 1987;14:262-266.
50. Petty HR, Hafeman DG, McConnell HM. Disappearance of macrophage surface folds after antibody-dependent phagocytosis. J Cell Biol 1981;89:223-229.
51. Royle SJ. The cellular functions of clathrin. Cell Mol Life Sci 2006;63:1823-1832.
52. Mellman I, Warren G. The road taken: Past and future foundations of membrane traffic. Cell 2000;100:99-112.
53. Schmid SL. Clathrin-coated vesicle formation and protein sorting: An integrated process. Annu Rev Biochem 1997;66:511-548.
54. Schekman R, Orci L. Coat proteins and vesicle budding. Science 1996;271:1526-1533.
55. Underwood RA, Carter WG, Usui ML, Olerud JE. Ultrastructural localization of integrin subunits {beta}4 and {alpha}3 within the migrating epithelial tongue of in vivo human wounds. J Histochem Cytochem 2009;57:123-142.
56. Sonnenberg A, Nievers M, Schaapveld R, Geerts D, Niessen C, Borradori L. Interaction of BP180 and alpha6beta4. J Invest Dermatol 1999;112:830-832.
57. Odland G, Ross R. Human wound repair. I. Epidermal regeneration. J Cell Biol 1968;39:135-151.
58. Ross R, Odland G. Human wound repair. II. Inflammatory cells, epithelial-mesenchymal interrelations, and fibrogenesis. J Cell Biol 1968;39:152-168.
59. Nguyen BP, Gil SG, Carter WG. Deposition of laminin 5 by keratinocytes regulates integrin adhesion and signaling. J Biol Chem 2000;275:31896-31907.
60. Carter WG, Ryan MC, Gahr PJ. Epiligrin, a new cell adhesion ligand for integrin alpha 3 beta 1 in epithelial basement membranes. Cell 1991;65:599-610.
61. Ishiko A, Shimizu H, Kikuchi A, Ebihara T, Hashimoto T, Nishikawa T. Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin. J Clin Invest 1993;91:1608-1615. (Pubitemid 23127364)
62. Tokuyasu KT. Use of poly(vinylpyrrolidone) and poly(vinyl alcohol) for cryoultramicrotomy. Histochem J 1989;21:163-171.
63. Tokuyasu KT. Immunochemistry on ultrathin frozen sections. Histochem J 1980;12:381-403.
64. Tokuyasu KT. A technique for ultracryotomy of cell suspensions and tissues. J Cell Biol 1973;57:551-565.
65. Badylak SF, Valentin JE, Ravindra AK, McCabe GP, Stewart-Akers AM. Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng Part A 2008;14:1835-1842.